Gender disparities in lung cancer incidence in the United States during 2001-2019.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 08 2023
03 08 2023
Historique:
received:
22
03
2023
accepted:
25
07
2023
medline:
7
8
2023
pubmed:
4
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
Lung cancer ranks as one of the top malignancies and the leading cause of cancer death in both males and females in the US. Using a cancer database covering the entire population, this study was to determine the gender disparities in lung cancer incidence during 2001-2019. Cancer patients were obtained from the National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology and End Results (SEER) database. The SEER*Stat software was applied to calculate the age-adjusted incidence rates (AAIR). Temporal changes in lung cancer incidence were analyzed by the Joinpoint software. A total of 4,086,432 patients (53.3% of males) were diagnosed with lung cancer. Among them, 52.1% were 70 years or older, 82.7% non-Hispanic white, 39.7% from the South, and 72.6% non-small cell lung cancer (NSCLC). The AAIR of lung cancer continuously reduced from 91.0 per 100000 to 59.2 in males during the study period, while it increased from 55.0 in 2001 to 56.8 in 2006 in females, then decreased to 48.1 in 2019. The female to male incidence rate ratio of lung cancer continuously increased from 2001 to 2019. Gender disparities were observed among age groups, races, and histological types. In those aged 0-54 years, females had higher overall incidence rates of lung cancer than males in recent years, which was observed in all races (except non-Hispanic black), all regions, and adenocarcinoma and small cell (but not squamous cell). Non-Hispanic black females aged 0-54 years had a faster decline rate than males since 2013. API females demonstrated an increased trend during the study period. Lung cancer incidence continues to decrease with gender disparities among age groups, races, regions, and histological types. Continuous anti-smoking programs plus reduction of related risk factors are necessary to lower lung cancer incidence further.
Identifiants
pubmed: 37537259
doi: 10.1038/s41598-023-39440-8
pii: 10.1038/s41598-023-39440-8
pmc: PMC10400573
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12581Informations de copyright
© 2023. Springer Nature Limited.
Références
Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17–48. https://doi.org/10.3322/caac.21763 (2023).
doi: 10.3322/caac.21763
pubmed: 36633525
Lewis, D. R., Check, D. P., Caporaso, N. E., Travis, W. D. & Devesa, S. S. US lung cancer trends by histologic type. Cancer 120, 2883–2892. https://doi.org/10.1002/cncr.28749 (2014).
doi: 10.1002/cncr.28749
pubmed: 25113306
Houston, K. A., Henley, S. J., Li, J., White, M. C. & Richards, T. B. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009. Lung Cancer 86, 22–28. https://doi.org/10.1016/j.lungcan.2014.08.001 (2014).
doi: 10.1016/j.lungcan.2014.08.001
pubmed: 25172266
Patel, M. I. et al. Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years. Lung Cancer 108, 140–149. https://doi.org/10.1016/j.lungcan.2017.03.014 (2017).
doi: 10.1016/j.lungcan.2017.03.014
pubmed: 28625626
Tabatabai, M. A. et al. Racial and gender disparities in incidence of lung and bronchus cancer in the United States: A longitudinal analysis. PLoS One 11, e0162949. https://doi.org/10.1371/journal.pone.0162949 (2016).
doi: 10.1371/journal.pone.0162949
pubmed: 27685944
pmcid: 5042522
Lu, T. et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag. Res. 11, 943–953. https://doi.org/10.2147/CMAR.S187317 (2019).
doi: 10.2147/CMAR.S187317
pubmed: 30718965
pmcid: 6345192
Zhong, Y. J. et al. Trends and patterns of disparities in burden of lung cancer in the United States, 1974–2015. Front. Oncol. 9, 404. https://doi.org/10.3389/fonc.2019.00404 (2019).
doi: 10.3389/fonc.2019.00404
pubmed: 31214489
pmcid: 6555199
Jemal, A. et al. Higher lung cancer incidence in young women than young men in the United States. N. Engl. J. Med. 378, 1999–2009. https://doi.org/10.1056/NEJMoa1715907 (2018).
doi: 10.1056/NEJMoa1715907
pubmed: 29791813
pmcid: 7717174
National. Program of Cancer Registries and Surveillance, Epidemiology and End Results Program SEER*Stat Database: NPCR and SEER Incidence - U.S. Cancer Statistics Public Use Research Database, 2021 Submission (2001–2019). United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Released June 2022. Accessed at www.cdc.gov/cancer/uscs/public-use .
Tiwari, R. C., Clegg, L. X. & Zou, Z. Efficient interval estimation for age-adjusted cancer rates. Stat. Methods Med. Res. 15, 547–569. https://doi.org/10.1177/0962280206070621 (2006).
doi: 10.1177/0962280206070621
pubmed: 17260923
Islami, F. et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, CA. Cancer J. Clin. 68, 31–54. https://doi.org/10.3322/caac.21440 (2018).
doi: 10.3322/caac.21440
Cornelius, M. E., Loretan, C. G., Wang, T. W., Jamal, A. & Homa, D. M. Tobacco product use among adults—United States, 2020. MMWR Morb. Mortal Wkly Rep. 71, 397–405. https://doi.org/10.15585/mmwr.mm7111a1 (2022).
doi: 10.15585/mmwr.mm7111a1
pubmed: 35298455
pmcid: 8942309
Giovino, G. A. et al. Differential trends in cigarette smoking in the USA: Is menthol slowing progress?. Tob. Control 24, 28–37. https://doi.org/10.1136/tobaccocontrol-2013-051159 (2015).
doi: 10.1136/tobaccocontrol-2013-051159
pubmed: 23997070
Blot, W. J. et al. Lung cancer risk among smokers of menthol cigarettes. J. Natl. Cancer Inst. 103, 810–816. https://doi.org/10.1093/jnci/djr102 (2011).
doi: 10.1093/jnci/djr102
pubmed: 21436064
pmcid: 3096798
Jemal, A., Ma, J., Rosenberg, P. S., Siegel, R. & Anderson, W. F. Increasing lung cancer death rates among young women in southern and midwestern States. J. Clin. Oncol. 30, 2739–2744. https://doi.org/10.1200/JCO.2012.42.6098 (2012).
doi: 10.1200/JCO.2012.42.6098
pubmed: 22734032
pmcid: 3402885
Jeon, J. et al. Smoking and lung cancer mortality in the United States From 2015 to 2065: A comparative modeling approach. Ann. Intern. Med. 169, 684–693. https://doi.org/10.7326/M18-1250 (2018).
doi: 10.7326/M18-1250
pubmed: 30304504
pmcid: 6242740
Siegel, D. A., Fedewa, S. A., Henley, S. J., Pollack, L. A. & Jemal, A. Proportion of never smokers among men and women with lung cancer in 7 US States. JAMA Oncol. 7, 302–304. https://doi.org/10.1001/jamaoncol.2020.6362 (2021).
doi: 10.1001/jamaoncol.2020.6362
pubmed: 33270100
Wakelee, H. A. et al. Lung cancer incidence in never smokers. J. Clin. Oncol. 25, 472–478. https://doi.org/10.1200/JCO.2006.07.2983 (2007).
doi: 10.1200/JCO.2006.07.2983
pubmed: 17290054
North, C. M. & Christiani, D. C. Women and lung cancer: What is new?. Semin. Thorac. Cardiovasc. Surg. 25, 87–94. https://doi.org/10.1053/j.semtcvs.2013.05.002 (2013).
doi: 10.1053/j.semtcvs.2013.05.002
pubmed: 24216523
Akhtar, N. & Bansal, J. G. Risk factors of lung cancer in nonsmoker. Curr. Probl. Cancer 41, 328–339. https://doi.org/10.1016/j.currproblcancer.2017.07.002 (2017).
doi: 10.1016/j.currproblcancer.2017.07.002
pubmed: 28823540
Thun, M. J. et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med. 5, e185. https://doi.org/10.1371/journal.pmed.0050185 (2008).
doi: 10.1371/journal.pmed.0050185
pubmed: 18788891
pmcid: 2531137
Baiu, I., Titan, A. L., Martin, L. W., Wolf, A. & Backhus, L. The role of gender in non-small cell lung cancer: A narrative review. J. Thorac. Dis. 13, 3816–3826. https://doi.org/10.21037/jtd-20-3128 (2021).
doi: 10.21037/jtd-20-3128
pubmed: 34277072
pmcid: 8264700
Cufari, M. E. et al. Increasing frequency of non-smoking lung cancer: Presentation of patients with early disease to a tertiary institution in the UK. Eur. J. Cancer 84, 55–59. https://doi.org/10.1016/j.ejca.2017.06.031 (2017).
doi: 10.1016/j.ejca.2017.06.031
pubmed: 28783541
Samet, J. M. et al. Lung cancer in never smokers: Clinical epidemiology and environmental risk factors. Clin. Cancer Res. 15, 5626–5645. https://doi.org/10.1158/1078-0432.CCR-09-0376 (2009).
doi: 10.1158/1078-0432.CCR-09-0376
pubmed: 19755391
pmcid: 3170525
Lebrett, M. B. et al. Targeting lung cancer screening to individuals at greatest risk: The role of genetic factors. J. Med. Genet. 58, 217–226. https://doi.org/10.1136/jmedgenet-2020-107399 (2021).
doi: 10.1136/jmedgenet-2020-107399
pubmed: 33514608
Xiong, W. M. et al. The association between human papillomavirus infection and lung cancer: A system review and meta-analysis. Oncotarget 8, 96419–96432. https://doi.org/10.18632/oncotarget.21682 (2017).
doi: 10.18632/oncotarget.21682
pubmed: 29221217
pmcid: 5707111
Barrera-Rodriguez, R. & Morales-Fuentes, J. Lung cancer in women. Lung Cancer Auckl 3, 79–89. https://doi.org/10.2147/LCTT.S37319 (2012).
doi: 10.2147/LCTT.S37319
pubmed: 28210127
pmcid: 5312492
Mollerup, S. et al. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int. J. Cancer 119, 741–744. https://doi.org/10.1002/ijc.21891 (2006).
doi: 10.1002/ijc.21891
pubmed: 16557573
Stapelfeld, C., Dammann, C. & Maser, E. Sex-specificity in lung cancer risk. Int. J. Cancer 146, 2376–2382. https://doi.org/10.1002/ijc.32716 (2020).
doi: 10.1002/ijc.32716
pubmed: 31583690
Snyder, R. A., Hu, C. Y., DiBrito, S. R. & Chang, G. J. Association of Medicaid expansion with racial disparities in cancer stage at presentation. Cancer 128, 3340–3351. https://doi.org/10.1002/cncr.34347 (2022).
doi: 10.1002/cncr.34347
pubmed: 35818763
Bertakis, K. D., Azari, R., Helms, L. J., Callahan, E. J. & Robbins, J. A. Gender differences in the utilization of health care services. J. Fam. Pract. 49, 147–152 (2000).
pubmed: 10718692
Haiman, C. A. et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N. Engl. J. Med. 354, 333–342. https://doi.org/10.1056/NEJMoa033250 (2006).
doi: 10.1056/NEJMoa033250
pubmed: 16436765
Clegg, L. X. et al. Quality of race, hispanic ethnicity, and immigrant status in population-based cancer registry data: Implications for health disparity studies. Cancer Control 18, 177–187. https://doi.org/10.1007/s10552-006-0089-4 (2007).
doi: 10.1007/s10552-006-0089-4
Thrift, A. P. & Gudenkauf, F. J. Melanoma incidence among non-hispanic whites in All 50 US States from 2001 through 2015. J. Natl. Cancer Inst. 112, 533–539. https://doi.org/10.1093/jnci/djz153 (2020).
doi: 10.1093/jnci/djz153
pubmed: 31346623
Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33. https://doi.org/10.3322/caac.21708 (2022).
doi: 10.3322/caac.21708
pubmed: 35020204
Janssen-Heijnen, M. L. & Coebergh, J. W. The changing epidemiology of lung cancer in Europe. Lung Cancer 41, 245–258. https://doi.org/10.1016/s0169-5002(03)00230-7 (2003).
doi: 10.1016/s0169-5002(03)00230-7
pubmed: 12928116
Au, J. S., Mang, O. W., Foo, W. & Law, S. C. Time trends of lung cancer incidence by histologic types and smoking prevalence in Hong Kong 1983–2000. Lung Cancer 45, 143–152. https://doi.org/10.1016/j.lungcan.2004.01.012 (2004).
doi: 10.1016/j.lungcan.2004.01.012
pubmed: 15246184
Toyoda, Y., Nakayama, T., Ioka, A. & Tsukuma, H. Trends in lung cancer incidence by histological type in Osaka, Japan. Jpn. J. Clin. Oncol. 38, 534–539. https://doi.org/10.1093/jjco/hyn072 (2008).
doi: 10.1093/jjco/hyn072
pubmed: 18689853
pmcid: 2525496
Devesa, S. S., Bray, F., Vizcaino, A. P. & Parkin, D. M. International lung cancer trends by histologic type: Male:female differences diminishing and adenocarcinoma rates rising. Int. J. Cancer 117, 294–299. https://doi.org/10.1002/ijc.21183 (2005).
doi: 10.1002/ijc.21183
pubmed: 15900604
Khuder, S. A. & Mutgi, A. B. Effect of smoking cessation on major histologic types of lung cancer. Chest 120, 1577–1583. https://doi.org/10.1378/chest.120.5.1577 (2001).
doi: 10.1378/chest.120.5.1577
pubmed: 11713137
Kenfield, S. A., Wei, E. K., Stampfer, M. J., Rosner, B. A. & Colditz, G. A. Comparison of aspects of smoking among the four histological types of lung cancer. Tob. Control 17, 198–204. https://doi.org/10.1136/tc.2007.022582 (2008).
doi: 10.1136/tc.2007.022582
pubmed: 18390646
Fidler-Benaoudia, M. M., Torre, L. A., Bray, F., Ferlay, J. & Jemal, A. Lung cancer incidence in young women vs young men: A systematic analysis in 40 countries. Int. J. Cancer 147, 811–819. https://doi.org/10.1002/ijc.32809 (2020).
doi: 10.1002/ijc.32809
pubmed: 32020598
Pesch, B. et al. Cigarette smoking and lung cancer–relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int. J. Cancer 131, 1210–1219. https://doi.org/10.1002/ijc.27339 (2012).
doi: 10.1002/ijc.27339
pubmed: 22052329
Wang, Q. et al. SCLC: Epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection. J. Thorac. Oncol. 18, 31–46. https://doi.org/10.1016/j.jtho.2022.10.002 (2023).
doi: 10.1016/j.jtho.2022.10.002
pubmed: 36243387
Haddad, D. N., Sandler, K. L., Henderson, L. M., Rivera, M. P. & Aldrich, M. C. Disparities in lung cancer screening: A review. Ann. Am. Thorac. Soc. 17, 399–405. https://doi.org/10.1513/AnnalsATS.201907-556CME (2020).
doi: 10.1513/AnnalsATS.201907-556CME
pubmed: 32017612
pmcid: 7175982
Miller, K. D. et al. Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J. Clin. 71, 466–487. https://doi.org/10.3322/caac.21695 (2021).
doi: 10.3322/caac.21695
pubmed: 34545941
Drope, J. et al. Who’s still smoking? Disparities in adult cigarette smoking prevalence in the United States. CA Cancer J. Clin. 68, 106–115. https://doi.org/10.3322/caac.21444 (2018).
doi: 10.3322/caac.21444
pubmed: 29384589
Gilpin, E. A. & Pierce, J. P. Demographic differences in patterns in the incidence of smoking cessation: United States 1950–1990. Ann. Epidemiol. 12, 141–150. https://doi.org/10.1016/s1047-2797(01)00266-6 (2002).
doi: 10.1016/s1047-2797(01)00266-6
pubmed: 11897171
Shin, D., Fishman, M. D. C., Ngo, M., Wang, J. & LeBedis, C. A. The impact of social determinants of health on lung cancer screening utilization. J. Am. Coll. Radiol. 19, 122–130. https://doi.org/10.1016/j.jacr.2021.08.026 (2022).
doi: 10.1016/j.jacr.2021.08.026
pubmed: 35033299
pmcid: 8820269
Jemal, A. et al. Changes in black-white difference in lung cancer incidence among young adults. JNCI Cancer Spectr. 4, pkaa055. https://doi.org/10.1093/jncics/pkaa055 (2020).
doi: 10.1093/jncics/pkaa055
pubmed: 32851203
pmcid: 7440250